Cargando…

Relationship of H-ras-1, L-myc, and p53 polymorphisms with lung cancer risk and prognosis.

Proto-oncogenes (H-ras-1 and L-myc) and tumor-suppressor gene (p53) loci have been implicated in lung carcinogenesis. DNA restriction fragment length polymorphisms at these gene loci are being evaluated in a case-control study as markers predictive of risk for cancer or of prognosis when cancer is p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Weston, A, Caporaso, N E, Perrin, L S, Sugimura, H, Tamai, S, Krontiris, T G, Trump, B F, Hoover, R N, Harris, C C
Formato:	Texto
Lenguaje:	English
Publicado:	1992
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1519610/ https://www.ncbi.nlm.nih.gov/pubmed/1486864

Ejemplares similares

Polycyclic aromatic hydrocarbon-DNA adducts and the CYP1A1 restriction fragment length polymorphism.
por: Shields, P G, et al.
Publicado: (1992)

Polymorphisms of H-ras-1 and p53 in breast cancer and lung cancer: a meta-analysis.
por: Weston, A, et al.
Publicado: (1997)

Molecular Analysis of Oncogenes, ras Family Genes (N‐ras, K‐ras, H‐ras), myc Family Genes (c‐myc, N‐myc) and mdm2 in Natural Killer Cell Neoplasms
por: Sugimoto, Kei‐ji, et al.
Publicado: (2002)

The debrisoquine metabolic phenotype and DNA-based assays: implications of misclassification for the association of lung cancer and the debrisoquine metabolic phenotype.
por: Caporaso, N E, et al.
Publicado: (1992)

Analysis of the c‐myc, K‐ras and p53 Genes in Methylcholanthrene induced Mouse Sarcomas
por: Watanabe, Hiroshi, et al.
Publicado: (1999)

Human hypervariable sequences in risk assessment: rare Ha-ras alleles in cancer patients.
por: Krontiris, T G, et al.
Publicado: (1987)

Altered expression of Bcl-2, c-Myc, H-Ras, K-Ras, and N-Ras does not influence the course of mycosis fungoides
por: Maj, Joanna, et al.
Publicado: (2013)

Myc Cooperates with Ras by Programming Inflammation and Immune Suppression
por: Kortlever, Roderik M., et al.
Publicado: (2017)

Polymorphism of p53 in cancer prognosis
por: Pillai, Radhakrishna Madhavan, et al.
Publicado: (2016)

Resistance to anticancer drugs in NIH3T3 cells transfected with c-myc and/or c-H-ras genes.
por: Niimi, S., et al.
Publicado: (1991)

Metabolic convergence on lipogenesis in RAS, BCR-ABL, and MYC-driven lymphoid malignancies
por: Liefwalker, Daniel F., et al.
Publicado: (2021)

Critical role of Myc activation in mouse hepatocarcinogenesis induced by the activation of AKT and RAS pathways
por: Xin, B, et al.
Publicado: (2017)

A Driver Never Works Alone—Interplay Networks of Mutant p53, MYC, RAS, and Other Universal Oncogenic Drivers in Human Cancer
por: Grzes, Maria, et al.
Publicado: (2020)

NO CORRELATION BETWEEN L‐myc RESTRICTION FRAGMENT LENGTH POLYMORPHISM AND MALIGNANCY OF HUMAN COLORECTAL CANCERS
por: Ikeda, Isuzu, et al.
Publicado: (1988)

hTERT, MYC and TP53 deregulation in gastric preneoplastic lesions
por: Silva, Tanielly Cristina Raiol, et al.
Publicado: (2012)

Combined Inactivation of MYC and K-Ras Oncogenes Reverses Tumorigenesis in Lung Adenocarcinomas and Lymphomas
por: Tran, Phuoc T., et al.
Publicado: (2008)

Constitutive CCND1/CDK2 Activity Substitutes for p53 Loss, or MYC or Oncogenic RAS Expression in the Transformation of Human Mammary Epithelial Cells
por: Junk, Damian J., et al.
Publicado: (2013)

Susceptibility to apoptosis is differentially regulated by c-myc and mutated Ha-ras oncogenes and is associated with endonuclease availability.
por: Arends, M. J., et al.
Publicado: (1993)

ASPP1 and ASPP2 bind active RAS, potentiate RAS signalling and enhance p53 activity in cancer cells
por: Wang, Y, et al.
Publicado: (2013)

Distinct clinicopathological characteristics, genomic alteration and prognosis in breast cancer with concurrent TP53 mutation and MYC amplification
por: Lin, Xiaoyi, et al.
Publicado: (2022)

Tumors Induced in Mice by Direct Inoculation of Plasmid DNA Expressing Both Activated H-ras and c-myc
por: Sheng-Fowler, Li, et al.
Publicado: (2010)

Epigenetic activation of a RAS/MYC axis in H3.3K27M-driven cancer
por: Pajovic, Sanja, et al.
Publicado: (2020)

MYC and RAS are unable to cooperate in overcoming cellular senescence and apoptosis in normal human fibroblasts
por: Zhang, Fan, et al.
Publicado: (2018)

Polymorphisms cMyc-N11S and p27-V109G and breast cancer risk and prognosis
por: Figueiredo, Jane C, et al.
Publicado: (2007)

Rodent fibroblast tumours expressing human myc and ras genes: growth, metastasis and endogenous oncogene expression.
por: Wyllie, A. H., et al.
Publicado: (1987)

TP53 codon 72 polymorphism is associated with FGFR3 and RAS mutation in non-muscle-invasive bladder cancer
por: Kawahara, Takashi, et al.
Publicado: (2019)

The Gain of Function of p53 Mutant p53S in Promoting Tumorigenesis by Cross-talking with H-RasV12
por: Jia, Shuting, et al.
Publicado: (2012)

Alterations in the K-ras and p53 genes in rat lung tumors.
por: Belinsky, S A, et al.
Publicado: (1997)

Ha-ras restriction fragment length polymorphisms in colorectal cancer.
por: Wyllie, F. S., et al.
Publicado: (1988)

Characterization of ARF-BP1/HUWE1 Interactions with CTCF, MYC, ARF and p53 in MYC-Driven B Cell Neoplasms
por: Qi, Chen-Feng, et al.
Publicado: (2012)

Genome-wide analysis of p53-regulated transcription in Myc-driven lymphomas
por: Tonelli, C, et al.
Publicado: (2017)

Mutational status of K- ras and TP53 genes in primary sarcomas of the heart
por: Garcia, J M, et al.
Publicado: (2000)

The relationship between microvessel count and the expression of vascular endothelial growth factor, p53, and K-ras in non-small cell lung cancer.
por: Kang, Y. H., et al.
Publicado: (2001)

Bcl-2 protein expression: association with p53 and prognosis in colorectal cancer.
por: Kaklamanis, L., et al.
Publicado: (1998)

FSH receptor binding inhibitor impacts K-Ras and c-Myc of ovarian cancer and signal pathway
por: Wei, Suocheng, et al.
Publicado: (2018)

Oncogenic K-ras confers SAHA resistance by up-regulating HDAC6 and c-myc expression
por: Wang, Qun, et al.
Publicado: (2016)

Polymorphic variants of H-RAS protooncogene and their possible role in bladder cancer etiology
por: Traczyk, Magdalena, et al.
Publicado: (2012)

Study on association between H-ras gene polymorphism and gastric adenocarcinoma risk
por: Rostami, Masoumeh, et al.
Publicado: (2013)

Microsatellite Instability and k‐ras, p53 Mutations in Thyroid Lymphoma
por: Takakuwa, Tetsuya, et al.
Publicado: (2000)

The human Tp53 Arg72Pro polymorphism explains different functional prognosis in stroke
por: Gomez-Sanchez, Jose C., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_6nvulklj1uk0q3vn748hond7co